Research is being conducted on the use of CAR-T cell therapy in combination with other treatments for various types of cancer, including acute myeloid leukemia and lymphomas. The potential of combining CAR-T therapy with other approaches, such as small-molecule targeted drugs and base edited "universal" donor CAR T-cell strategies, is being explored. The field of CAR-T cell therapy is actively evolving, with multiple companies and studies investigating its applications and potential combinations for cancer treatment.